MSNBC
Gimme Some Truth: Jen Rubin
Jen Rubin discusses the ‘Morning Joe’ fallout, MSNBC, and the bleak future of cable news
Jen Rubin is a commentator who writes opinion columns for The Washington Post. Previously she worked at Commentary, PJ Media, Human Events, and The Weekly Standard. Her work has been published in media outlets including Politico, New York Post, New York Daily News, National Review, and The Jerusalem Post.
A conservative political commentator throughout most of her career, she became a vocal critic of President Donald Trump and in September 2020, she announced that she no longer identified as a conservative.[2] In 2021, she became a staunch advocate of the Biden administration.
Sarah Kendzior: “Get this crime family out of the White House!”
The Hobbledehoy never miss and proudly share the latest episode of GasLit Nation and we think Sarah Kendzior is the Woodward-Bernstein of our times. Here is a screenshot-video of her call to action on MSNBC.
Did MSNBC purposely silence Sen. Liz Warren’s questioning on Covid vaccine profiteering?
There was a very odd cut-away from Senator Elizabeth Warren during today’s televised Select Subcommittee on Coronavirus Crisis hearing. Just as Senator Warren begins her question about the potential for conflict of interest involving Trump’s chief adviser for the White House vaccine program, someone at NBC/Comcast master control gives the tv director the “suggestion” to cut away. Why?
Trump’s chief adviser and so-called “vaccine czar” Moncef Slaoui, stepped down from his position on the board of directors at Moderna, a Massachusetts-based pharmaceutical company which is already planning a clinical trial for a vaccine it developed, to take on the job. His White House position is unpaid, according to the Associated Press.
But Securities and Exchange Commission filings show that Slaoui still holds more than 150,000 stock options in Moderna. Those offerings were valued at more than $10 million on Monday before the company’s stock shot up after it reported promising early results from its vaccine testing. Shares have nearly tripled in value since the start of the year, Business Insider reported.
Moderna’s stock skyrocketed last month after the company announced it had received $483 million in federal funding for its vaccine development.
Sources: Salon
• Return of my Fucking Bitch
• Believe Your Lying Eyes – It Was Murder
• History is Watching